Chamber and committees

The COVID-19 statistical report which is published weekly includes a section for COVID-19 vaccinations by Joint Committee on Vaccination and Immunisation (JCVI) priority group, including first, second, and third/booster doses for frontline social care workers. This cohort is made up of registered Scottish Social Services Council staff and does not include those without professional registration.

This data can be found at. https://publichealthscotland.scot/publications/show-all-releases?id=20580.

The Gateway Review into Scotland’s Deposit Return Scheme (DRS), which was published on 14 December 2021, gives a preparedness estimate of 12-24 months for individual stakeholders including retailers. This informed their judgement that a full implementation date of July-September 2023 was possible albeit with significant risk.

The Gateway Review does not give a breakdown of preparedness estimates for individual businesses. Businesses interviewed separately by SG typically gave ranges of preparedness estimates, which broadly aligned with the findings of the Gateway Review, rather than an exact time.

Modelling by Zero Waste Scotland (ZWS) projects that 29 of Scotland’s 32 local authorities will incur a net financial benefit from the implementation of Scotland’s Deposit Return Scheme (DRS). Local authorities are also expected to benefit from a reduction in the impact of litter, and from efficiencies to collection services following the implementation of DRS.

ZWS has no current plans to update its modelling. However, it is engaging with individual local authorities, in particular the three currently projected not to make savings, to assess the impacts of DRS on them and look at options for service improvements.

The COVID-19 statistical report which is published weekly includes a section for COVID-19 vaccinations by Joint Committee on Vaccination and Immunisation (JCVI) priority group, including first, second, and third/booster doses for frontline social care workers. This cohort is made up of registered Scottish Social Services Council staff and does not include those without professional registration.

This data can be found at. https://publichealthscotland.scot/publications/show-all-releases?id=20580.

The data specified in the question is held in a range of different data sources as summarised below. As each element of the answer is taken from a different data source there will be variations in methodology which mean that they are not directly comparable.

The Carbon Footprint of Scotland’s Household Waste publication published by Zero Waste Scotland ( 2019 Carbon Metric HH Brief - V01.00.pdf (zerowastescotland.org.uk) ) provides estimates of emissions from household waste. The relevant information is provided in the following table.

The UK Government has secured a further 4.25m patient courses of antiviral treatments to reduce the impact of COVID-19 and the Omicron variant across the UK. This includes 2.5 million patient courses of Paxlovid (PF-07321332+ritonavir (co-packaged)) from Pfizer and 1.75 million patient courses of molnupiravir from Merck Sharp and Dohme.

This is in addition to the 730,000 patient courses of these COVID-19 antivirals already secured - 480,000 courses of molnupiravir and 250,000 courses of PF-07321332+ritonavir (co-packaged), as announced on 20 October 2021. These treatments are a further measure to protect against COVID-19, in addition to vaccinations, which remain our best defence against this virus.

The UK Government takes initial receipt of stock, with proportionate supplies distributed to the four UK nations. In Scotland, NHS National Procurement allocates supplies to Health Boards depending on local need. There is sufficient supply to meet this current deployment, in line with need.

The eligibility criteria for direct access to new COVID-19 treatments was developed by an independent expert working group commissioned by the UK Department of Health and Social Care and is based on detailed clinical evidence. The criteria are set out in a UK-wide clinical commissioning policy . The policy targets those higher risk individuals who have the potential to both be least likely to generate a material immune response to vaccines and be at highest risk of disease progression, hospitalisation and death.

From 22 December 2021, adults and children (aged 12 years and above) are eligible to be assessed for their suitability for new COVID-19 treatments if they:

• have received a positive PCR test for COVID-19 in the last five days; and
• have symptoms of COVID-19 that started in the previous five days; and
• are associated with one of the patient groups considered at high risk from coronavirus and with a clinical condition prioritised for treatment.

Further information is available on NHS Inform .

In addition to the direct access arrangements described above for the most vulnerable, coronavirus oral antiviral treatments are being evaluated through a UK-wide study called PANORAMIC, run by the University of Oxford.

The outcomes from the study will enable the NHS to fully understand how best to make use of these treatments in the future.

The information displayed on the NHS Scotland Covid Status App is described in detail in the privacy notice .

Venues are required to display a privacy notice in areas where the app will be used. This will help members of the public understand the purpose of the data processing that will be done by the app and provide assurance about how their personal data will be safeguarded by the venue staff. A privacy notice template can be found here .

Rigorous data minimisation controls have been put in place, including the use of the “Green Tick” for domestic purposes, to ensure that as little personal data is displayed as possible, through the NHS Scotland COVID Pass Verifier app.

This information is not routinely published. We are currently undertaking an exercise to analyse the data about how many people with learning disabilities and autism have died in inpatient units in Scotland. I will write to the member in due course when we have the information.

Booster information was made available in the international travel section of the NHS Covid Status App on 9 December and on paper/pdf versions of certificates from 13 December.

The inclusion of booster information will allow those travelling to the small number of countries that are seeking evidence of more recent doses to provide evidence of their booster or third vaccination.

The domestic section of the NHS Covid Status App was updated on 13 January to include booster information. From Monday 17 January, for the purposes of domestic Covid certification, a person will need to show they have had a booster to be considered ‘fully vaccinated’ if their last vaccine dose was more than four months ago. This is in recognition of vaccine waning against Omicron, and will ensure that the scheme provides a greater level of protection to those attending venues.